Manufacturers Life Insurance Company, The Nurix Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 31,025 shares of NRIX stock, worth $403,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,025
Previous 30,383
2.11%
Holding current value
$403,014
Previous $682,000
14.37%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding NRIX
# of Institutions
185Shares Held
70.6MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$88.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$56.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$54.5 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$50.4 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.59MShares$46.6 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $612M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...